Articles
Zainab Shinkafi-Bagudu: What Africa’s First Lady of Cancer Will Bring to the Top Global Advocacy Role
Experience gained over decades of tackling cancer and supporting patients in Africa’s most populous country gives Zainab Shinkafi-Bagudu unique insights and influence to help bring about progress in similar settings across the globe. She talked to CancerWorld journalist, Diana Mwango,…
CancerWorld #104 (June 2025)
At CancerWorld, we don’t just publish science, we publish stories. As Alberto Costa, reminds us: CancerWorld is not about papers, it’s about people. The June, 2025 issue brings that philosophy into sharp focus. On our dual cover, we feature two…
Princess Adila: Her Royal Highness, Her Human Mission
Inside the remarkable journey of Princess Adila bint Abdullah Al Saud. An exclusive interview for CancerWorld. When I entered the room, it felt as though I had stepped into a page from an Arabian fairytale. The room was quiet and…
Back on Screen: The Return of Smoking in Films and Its Public Health Implications
May 31 is “World No Tobacco Day” Smoking is one of the major factors for tumors, not only lung cancer. This year’s World No Tobacco Day (WNTD) campaign aims “to reveal the strategies employed by the tobacco and nicotine industries…
Albinism And Skin Cancer In Africa: Tackling The Prevention Needs Of A Stigmatised Population
People with albinism in Africa face many obstacles, including a significantly higher risk of skin cancer due to intense sun exposure and lack of melanin, making prevention and access to protective care essential. CancerWorld journalist, Esther Nakkazi, explores some of…
Common Diabetes Medication Could Protect Heart Health During Cancer Treatment
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a common type of diabetes medication, may protect the heart during and after cancer treatment. The systematic review and meta-analysis, published in European Journal of Preventive Cardiology on 6 March, shows that SGLT2 inhibitors halve…
Why Patient-Reported Outcomes are Rarely Used in Trials, and How We Change That
If drug developers design trials to measure how well their drug addresses the issues most important to the target patient community, we could expect to end up with better drugs. Integrating patient-reported outcomes into clinical trials is the way to…
A Promise Kept: How Samvel Danielyan Lifted Pediatric Cancer Survival from Zero to 70%
In a country bruised by war, in a hospital crumbling under the weight of poverty and silence, one man made an impossible promise and kept it. Samvel Danielyan’s story is not the story of easy heroes. It is a story…
Together, She Changed Everything: Martine Piccart ’s Fight Against Breast Cancer
Prof. Martine Piccart grew up in a house where medicine was part of the air. Her father, a gynecologist, treated patients at home. “I admired him deeply,” she says. “He helped people. I saw that up close. It left a…
A Vision for Cancer Policy in Europe: An Interview with MEP Nikos Papandreou
CancerWorld had the opportunity to interview Nikos Papandreou, Member of the European Parliament and a dedicated advocate for cancer policy reform. With a background in politics, economics, and healthcare policy, Mr. Papandreou has been at the forefront of tackling Europe’s…